About kniest chondrodystrophy

What is kniest chondrodystrophy?

Kniest dysplasia is one of several forms of dwarfism that is caused by a change (mutation) in a gene known as COL2A1. This gene is involved in the production of a particular protein that forms type 2 collagen, which is essential for the normal development of bones and other connective tissue. Changes in the composition of type 2 collagen lead to abnormal skeletal growth and, thus, to a variety of dwarfing conditions known as skeletal dysplasias.

Some of the signs and symptoms of Kniest dysplasia, such as short stature, enlarged knees, and cleft palate, are usually present at birth. Other characteristics may not appear for two or three years.

What are the symptoms for kniest chondrodystrophy?

People with Kniest dysplasia are known to have an unusually short stature; short, deformed arms and legs; a chest that is “barrel-shaped” and abnormally short; and a relatively long trunk. Later in life, Short trunk dwarfism develops due to curvature of the spine and enlargement of the joints.

People with Kniest dysplasia have an unusually flat face with protruding eyes, and a low nasal bridge. A Cleft palate may also be present, and Speech impairment may occur. Involvement of the eyes may include nearsightedness (myopia) that can progress to retinal detachment and cataracts. Dislocated eye lenses, drooping of the eyelids (blepharoptosis), possible Blindness with disease of the optic nerve, involvement of the spine or brain, and Glaucoma may also occur. As the person matures, the joints may become enlarged causing limited movement and pain. Limbs are short, often bowed, and there may be irregularities of the ends of the long bones (epiphyses). Contracted hips may cause walking difficulties and there may be a congenital flattening of the vertebrae and a hump of the spine. Affected individuals may sometimes exhibit hernias of the groin (inguinal) and navel (umbilical), frequent ear infections, slowed motor development and hearing loss.

Also characteristic of Kniest dysplasia are holes in the individual’s cartilage, creating a “Swiss-cheese” appearance in cartilage that is significant for diagnostic purposes.

One variant of Kniest dysplasia that is extremely rare is known as Kniest-like dysplasia with pursed lips and ectopia lentis or Burton disease. It is characterized by a small mouth (microstomia) and pursed lips. In this variant, the collagen does not have the holes mentioned above.

What are the causes for kniest chondrodystrophy?

Kniest dysplasia is the result of a change (mutation) in the gene known as COL2A1, which produces (codes for) the protein that forms collagen type 2. This gene has been mapped to the following gene map locus: 12q13.11-q13.20. The disorder is transmitted from parent to child as an autosomal dominant trait. In some instances, the mutation appears to be spontaneous, occurring for no apparent reason.

Chromosomes, which are present in the nucleus of human cells, carry the genetic information for each individual. Human body cells normally have 46 chromosomes. Pairs of human chromosomes are numbered from 1 through 22 and the sex chromosomes are designated X and Y. Males have one X and one Y chromosome and females have two X chromosomes. Each chromosome has a short arm designated “p” and a long arm designated “q”. Chromosomes are further sub-divided into many bands that are numbered. For example, “12q13.11-q13.20” refers to a region between bands 13.11 and 13.20 on the long arm of chromosome 12. The numbered bands specify the location of the thousands of genes that are present on each chromosome.

Genetic diseases are determined by the combination of genes for a particular trait that are on the chromosomes received from the father and the mother.

Dominant genetic disorders occur when only a single copy of an abnormal gene is necessary for the appearance of the disease. The abnormal gene can be inherited from either parent, or can be the result of a new mutation (gene change) in the affected individual. The risk of passing the abnormal gene from affected parent to offspring is 50% for each pregnancy regardless of the sex of the resulting child.

Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.

All individuals carry a few abnormal genes. Parents who are close relatives (consanguineous) have a higher chance than unrelated parents to both carry the same abnormal gene, which increases the risk to have children with a recessive genetic disorder.

X-linked recessive genetic disorders are conditions caused by an abnormal gene on the X chromosome. Females have two X chromosomes but one of the X chromosomes is “turned off” and all of the genes on that chromosome are inactivated. Females who have a disease gene present on one of their X chromosomes are carriers for that disorder. Carrier females usually do not display symptoms of the disorder because it is usually the X chromosome with the abnormal gene that is “turned off”. A male has one X chromosome and if he inherits an X chromosome that contains a disease gene, he will develop the disease. Males with X-linked disorders pass the disease gene to all of their daughters, who will be carriers. A male cannot pass an X-linked gene to his sons because males always pass their Y chromosome instead of their X chromosome to male offspring. Female carriers of an X-linked disorder have a 25% chance with each pregnancy to have a carrier daughter like themselves, a 25% chance to have a non-carrier daughter, a 25% chance to have a son affected with the disease, and a 25% chance to have an unaffected son.

X-linked dominant disorders are also caused by an abnormal gene on the X chromosome, but in these rare conditions, females with an abnormal gene are affected with the disease. Males with an abnormal gene are more severely affected than females, and many of these males do not survive.

What are the treatments for kniest chondrodystrophy?

Treatment of Kniest syndrome usually consists of stabilization of lax joints, surgery to prevent contractures, and repair of retinal detachments and cleft palate. Genetic counseling may be of benefit for patients and their families. Other treatment is symptomatic and supportive.

What are the risk factors for kniest chondrodystrophy?

Kniest Syndrome is a rare disorder that affects males and females in equal numbers.

Is there a cure/medications for kniest chondrodystrophy?

There is no cure for Kniest chondrodystrophy, but there are some medications that can help control symptoms. The most common treatment is a drug called prednisone, which can be used to treat inflammation and swelling associated with the disease. Doctors will also often prescribe pain relievers like ibuprofen or acetaminophen to help manage symptoms like joint pain and stiffness.

Treatment options include surgery, orthotics, braces, and physical therapy. Surgery is usually the first line of treatment when it comes to Kniest chondrodystrophy. The goal of the surgery is to create an arch in the foot that will help with walking and balance.

Physical therapy can help reduce pain and strengthen muscles that have been weakened by the disease. This can prevent further deformities from occurring or make them less severe.

The medications for kniest chondrodystrophy are:

1. Hyaluronic acid injections: It is an injectable substance that helps to provide long-term pain relief for patients with knee pain associated with this condition. It works by lubricating the affected area and cushioning it from further damage. This helps to reduce pain and swelling, while promoting healing.

2. Nonsteroidal anti-inflammatory drugs (NSAIDs): These are commonly used to treat inflammation and pain associated with chronic conditions such as arthritis or other joint disorders like osteoarthritis (OA). They work by reducing inflammation and relieving pain by blocking certain substances in the body (eicosanoids) that cause these symptoms.

Stiffness in the knees (especially while walking),Pain in the knees (especially while walking),Trouble bending your knees fully or straightening them completely,Tightness and weakness in your calf muscles,Swelling of your ankles or feet
Congenital disorder of the joints,Abnormal development of the hipbone,Abnormal development of the femur,Hip joint disease,Iliopsoas muscle disease
Depomedrol,Deltasone,Prednisone,Methylprednisolone (Solu-Medrol)

Video related to kniest chondrodystrophy